Replies to post #330 on C4 Therapeutics Inc (CCCC)

[B RY]

"C4 Therapeutics Inc is strategically navigating its path through meticulous financial management, clinical advancements, and promising collaborations. These efforts are integral as the company continues to innovate in the challenging yet crucial area of targeted protein degradation, aiming to offer new therapeutic options for complex diseases."

https://finance.yahoo.com/news/c4-therapeutics-inc-cccc-q1-185238466.html

[B RY]

May 9,2024..."Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating"

https://finance.yahoo.com/news/stifel-adjusts-price-target-c4-145223168.html

[B RY]

Not pushing this, just like what researched.